BPA Call HT001425A0012-HT009026FG0110044
Award Date 1/8/26
Potential Completion Date 9/30/26
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency awarded a $21,834 firm-fixed-price Blanket Purchase Agreement (BPA) call to Sun Pharmaceutical Industries, Inc. for the supply of radiopharmaceuticals for nuclear medicine. The contract, which has no set-aside designation, will run through September 30, 2025. Sun Pharmaceutical, a for-profit manufacturer, has received previous prime contract awards from the Defense Health Agency for nuclear medicine imaging products, radiopharmaceutical delivery services, and...
- The Defense Health Agency awarded Sun Pharmaceutical Industries, Inc., a purchase order for various radiopharmaceuticals to support the Department of Radiology Nuclear Medicine operations at Fort Sam Houston, Texas. This firm fixed-price contract, awarded on November 15, 2025, carries a ceiling value of $521,223.75 and extends through September 30, 2030. The award was issued without a small business set-aside designation, reflecting the vendor's competitive standing in the federal pharmaceutical...
- This federal contract award to Sun Pharmaceutical Industries, Inc. by the Defense Health Agency is for the provision of nuclear medicine imaging products. The $986,924.50 firm-fixed-price purchase order covers the supply of medical imaging products for myocardial infarct imaging, diagnostic imaging of gallbladder disorders, and breast cancer nodule imaging. The contract has an ultimate completion date of March 11, 2026. This award is associated with Sun Pharmaceutical's existing Federal Supply...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc. for the supply of radiopharmaceuticals and related products. The contract has a ceiling value of $75,000.00 and a period of performance through September 30, 2024. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The DHA, a component of the Department of...
- The Defense Health Agency awarded a $77,206.25 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals with a completion date of September 30, 2026. The contract was awarded without a set-aside designation on October 1, 2025, with performance taking place at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a manufacturer of diagnostic medical imaging agents and radiopharmaceutical products based in North Billerica,...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Petnet Solutions, Inc. for radiopharmaceuticals and supplies, with a ceiling value of $215,747.85 and a firm fixed-price structure. The contract, awarded on October 1, 2024, carries an ultimate completion date of September 30, 2025, and will be performed at Fort Bliss, Texas. This award was made without a set-aside designation, reflecting Petnet Solutions' competitive standing in the specialized radiopharmaceutical...
- This firm fixed price Blanket Purchase Agreement (BPA) call award from the Defense Health Agency is for 123 DATSCAN services to diagnose imaging agents and radio-pharmaceuticals that can help with a Parkinsonian syndrome diagnosis. The contract has a potential value of $0.00 and performance will occur in Bethesda, Maryland. Medi-Physics, Inc. is the prime contractor selected to deliver the requested diagnosing services under this BPA call contract awarded on February 7, 2019 and completing on...
- This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Medi-Physics, Inc. (doing business as GE Healthcare), a subsidiary of General Electric Company, to provide radiopharmaceuticals. The $50,050 contract has a completion date of September 30, 2023. Medi-Physics is a manufacturer of specialized pharmaceutical products used in nuclear medicine procedures, including radioactive tracers for positron emission tomography (PET) scans and single-photon emission...